Escoreal, Gretyll T.
HRN: 22-70-85 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/14/2023
03/20/2023
IV
600 Mg
Q6
Cellulitis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes